Table 1:
Demographic and clinical characteristics. BMI=Body mass index, VUS=Variant of unknown significance, R0=no gross residual disease, NOS=not otherwise specified.
| N (%) | |
|---|---|
| N=226 | |
| Age, median, years (range) | 62 (23–88) |
| BMI, median, kg/m2 (range) | 27.1 (17.1–66.8) |
| Race/Ethnicity | |
| Hispanic or Latino | 22 (9.8) |
| Not Hispanic or Latino | 201 (88.9) |
| Unknown/not reported | 3 (1.3) |
| Known | 223 (98.7) |
| American Indian/Alaska native | 2 (0.9) |
| African American/Black | 14 (6.3) |
| Asian | 8 (3.6) |
| Caucasian/White | 199 (89.2) |
| Unknown/not reported | 3 (1.3) |
| CA125, median, U/mL (range) | 502.6 (10.9–12,472) |
| Primary disease site | |
| Fallopian tube | 9 (4.0) |
| Ovary | 194 (85.8) |
| Peritoneum | 23 (10.2) |
| Stage | |
| IIA | 1 (0.5) |
| IIB | 14 (6.2) |
| IIIA1 | 2 (0.9) |
| IIIA2 | 3 (1.3) |
| IIIB | 4 (1.8) |
| IIIC | 172 (76.1) |
| IVA | 12 (5.3) |
| IVB | 18 (7.9) |
| Histology | |
| Serous | 194 (85.8) |
| Endometrioid | 4 (1.8) |
| Clear cell | 8 (3.6) |
| Adenocarcinoma NOS | 1 (0.4) |
| Mixed | 12 (5.3) |
| Carcinosarcoma | 7 (3.1) |
| Residual disease | |
| R0 | 167 (80.3) |
| <1cm | 20 (9.6) |
| ≥1cm | 21 (10.1) |